购物车
- 全部删除
- 您的购物车当前为空
GSK3145095 是一种口服有效的 RIPK1 抑制剂,IC50 为 5 nM,具有潜在的免疫调节活性和抗肿瘤活性。
为众多的药物研发团队赋能,
让新药发现更简单!
GSK3145095 是一种口服有效的 RIPK1 抑制剂,IC50 为 5 nM,具有潜在的免疫调节活性和抗肿瘤活性。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,090 | 现货 | |
5 mg | ¥ 2,730 | 现货 | |
10 mg | ¥ 3,920 | 现货 | |
25 mg | ¥ 6,180 | 现货 | |
50 mg | ¥ 8,350 | 现货 | |
100 mg | ¥ 11,200 | 现货 | |
200 mg | ¥ 15,200 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 2,950 | 现货 |
产品描述 | GSK3145095 is an orally active inhibitor of RIPK1 with IC50 of 5 nM, with potential immunomodulatory activities and antineoplastic. |
靶点活性 | RIP1 kinase:6.3 nM (IC50) |
体外活性 | GSK3145095 potently binds to RIP1 with exquisite kinase specificity and has excellent activity in blocking RIP1 kinase-dependent cellular responses.?Highlighting its potential as a novel cancer therapy, the inhibitor was also able to promote a tumor suppressive T cell phenotype in pancreatic adenocarcinoma organ cultures. |
分子量 | 397.38 |
分子式 | C20H17F2N5O2 |
CAS No. | 1622849-43-7 |
Smiles | Fc1cc(F)c2NC(=O)[C@H](CCc2c1)NC(=O)c1n[nH]c(Cc2ccccc2)n1 |
密度 | 1.45 g/cm3 (Predicted) |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 245 mg/mL (616.54 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容